Results 11 to 20 of about 2,781,261 (274)

Proline-Based Carbamates as Cholinesterase Inhibitors [PDF]

open access: yesMolecules, 2017
Series of twenty-five benzyl (2S)-2-(arylcarbamoyl)pyrrolidine-1-carboxylates was prepared and completely characterized. All the compounds were tested for their in vitro ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), and
Hana Pizova   +10 more
doaj   +6 more sources

Cholinesterase inhibitors: drugs looking for a disease?

open access: goldPLoS Medicine, 2006
Maggini and colleagues examine the evidence on cholinesterase inhibitors for treating dementia. "What seemed a biologically plausible intervention," they say, "has not led to a proven, real improvement in patients' well-being."
Marina Maggini   +2 more
doaj   +6 more sources

Use of Inhibitors in Cholinesterase Histochemistry [PDF]

open access: bronzeNature, 1965
PRESENT-DAY histochemical methods for demonstrating cholinesterases require the use of inhibitors in order to distinguish between acetyl- (that is, true, or specific) cholinesterase (AChE) and butyryl- (non-specific) cholinesterase (ChE). The histochemical technique determines AChE and ChE together, so that if either enzyme is inhibited without the ...
P. C. Diegenbach
openalex   +4 more sources

Cholinesterase Inhibitors: Structure of Eserine [PDF]

open access: bronzeNature, 1973
ESERINE (physostigmine) was first isolated from the Calabar bean in the latter half of the last century1, but it was not until much later that its activity on the heart was demonstrated to be due to inhibition of acetylcholinesterase2,3. It is one of the few compounds that are equally active as inhibitors of both true and pseudo-cholinesterase and has ...
Trevor J. Petcher, Peter Pauling
openalex   +4 more sources

Cholinesterase inhibitors and hospitalization for bradycardia: a population-based study. [PDF]

open access: yesPLoS Medicine, 2009
BACKGROUND: Cholinesterase inhibitors are commonly used to treat dementia. These drugs enhance the effects of acetylcholine, and reports suggest they may precipitate bradycardia in some patients.
Laura Y Park-Wyllie   +5 more
doaj   +1 more source

Cholinesterase inhibitors for delirium [PDF]

open access: yesCochrane Database of Systematic Reviews, 2005
Delirium is now the preferred term to describe acute confusional states. It is experienced by 10 to 30% of all hospital inpatients. Delirium is potentially reversible and is related to several adverse outcomes, including increased hospital length of stay, poor functional status, persistent cognitive impairment, need for institutional care and probably ...
Ross Overshott   +2 more
openaire   +3 more sources

Association of cognitive enhancers and incident seizure risk in dementia: a population-based study

open access: yesBMC Geriatrics, 2022
Background Although individuals with dementia have a high risk of developing seizures, whether seizures are associated with cholinesterase inhibitors, which are commonly prescribed to treat individuals with dementia, remains unknown.
Junghee Ha   +5 more
doaj   +1 more source

Bioactivity-Guided Separation of Anti-Cholinesterase Alkaloids from Uncaria rhynchophlly (Miq.) Miq. Ex Havil Based on HSCCC Coupled with Molecular Docking

open access: yesMolecules, 2022
As an important source of cholinesterase inhibitors, alkaloids in natural products have high potential value in terms of exerting pharmacological activities.
Pengfei Yu   +8 more
doaj   +1 more source

Mass spectrometry in ocular drug research

open access: yesMass Spectrometry Reviews, EarlyView., 2023
Abstract Mass spectrometry (MS) has been proven as an excellent tool in ocular drug research allowing analyzes from small samples and low concentrations. This review begins with a short introduction to eye physiology and ocular pharmacokinetics and the relevance of advancing ophthalmic treatments.
Eva M. del Amo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy